Douglas Merrill Kolodny, Ph.D., Mba 🇺🇸 Email & Phone Number

Houston, Texas Area

• Charged with identifying, screening, and shaping high-impact, transformational concepts and building business cases (feasibility, desirability, and viability) for resourcing new technology platforms, establishing open innovation collaborations and/or pursuing aggressive business development.• Advised and consulted with alI divisions and presented growth recommendations to the executive teamSELECTED ACCOMPLISHMENTS• Identified strategic growth options for water, civil engineering, wood composites, biobased chemistries, 3D Printing and agrochemical sectors leading to new partnerships and investments.• Developed DCF and Monte Carlo-based NPV models to assess reward, highlight risk factors and profit drivers.

Philadelphia, Pa

Provided leadership in developing, adapting and executing an Open Innovation initiative focused on delivering external solutions as an enabler of growth. Identified, developed business cases and secured rights to proprietary & differentiated platform technologies, molecules or companies for adding value and competitive advantages to FMC's agricultural product portfolio. Led due diligence activities and served as primary negotiator for technology acquisitions and in-licensing deals SELECTED ACCOMPLISHMENTS• Built extensive network of third party strategic partners for sourcing novel licensing opportunities • Established expert network to provide objective vetting of third party technologies• Sourced over 200 innovative technologies in the areas of advanced materials, nanotechnology, drug delivery and biotechnology• Executed over 14 Termsheets for advancing select technologies into Proof of Concept testing• Conceptualized and championed business cases for several cutting edge applications of nanotechnologies for transforming delivery / spectrum of small molecule actives and enhancing pest detection within crop and urban pest control sectors, respectively.

Gaithersburg, Md

MaxCyte is a leader in providing clinical/commercial cell modification technologies. I was responsible for identifying and pursuing leads, managing all aspects of the sales cycle, and attracting new business by showcasing cell loading differentiation within the cell therapeutic and regenerative medicine space. Participated in all stages of the process leading to deal closure, including structure determination, valuation, negotiation and document preparation. SELECT ACCOMPLISHMENTS• Provided leadership in building the corporate Asian market strategy. Secured two seven-figure deals for immunotherapeutic based medicines directed at oncology markets.• Former Chairman of the Asian sub-committee for the Technology Council of Maryland

Savage, Md

Chesapeake PERL, Inc is a custom protein production company• Managed all business development efforts, including marketing, analyzing new opportunities, strategy development and negotiating contracts, collaborations and agreements.

Calverton, Md

MetaMorphix, Inc., a life sciences company, develops a pipeline of products and tests that addresses livestock sectors and enhances the health of companion animals.• Participated in developing new business opportunities and made recommendations for in / out licensing of growth & differentiation factors, immunopharmaceuticals and genomic platforms within the animal and human health sectors for cachexia, sarcopenia, muscular dystrophy, diabetes, and obesity.• Recipient of three Maryland Export Grants to secure Asian marketing partners

Baltimore, Maryland Area

Envirion developed novel biopesticides based on recombinant baculovirus technology• Co-launched Envirion in 2001 after negotiating exclusive, global licenses from the University of Maryland and BASF for recombinant baculovirus technologies for agricultural and pharmaceutical markets.SELECTED ACCOMPLISHMENTS• Negotiated and executed ancillary research and license agreements ensuring a defensible patent estate• Assumed lead role in deal negotiations, contract development, due diligence and other alliance development projects including JV discussions with Crompton (now Chemtura))

Columbia, Maryland

Biosys was a leading manufacturer and supplier of biopesticides for the agricultural and horticultural markets.• Secured partnerships and strategic foothold within Pacific Rim and managed all aspects of account development and sales efforts for new products with revenue potential exceeding $25 million per annum• Recipient of the Maryland Industrial Partnership Award for research leading to improvements in the production of baculoviruses and an Environmental/Energy Technology Grant

Columbia, Maryland

Coordinated and assessed international field testing programs for candidate biopesticides providing basis for assessing commercial potential and market expansion. Co-authored and assembled US EPA registration packages securing rapid approval of six novel agricultural products.

Columbia, Maryland

Company acquired by Crop Genetics International • Effectively provided strategic direction for product development and manufacturing of viral-based insecticides through two rounds of venture capital funding and sale of assets to a NASDAQ listed company• Coordinated and assessed POC efficacy trials with corporate, academic and institutional partners• Co-invented novel methods for producing baculoviruses on a commercial scale while establishing low-cost manufacturing leadership• Negotiated streamlined EPA data requirements thereby accelerating market entry by two years.

Baltimore, Maryland Area

• Consulted and engaged in contractual R&D for leading life science companies including DuPont, Abbott, Ecogen, Mycogen, and Novo Nordisk & the US Forest Service.• Hired by the U.S. Agency for International Development, to design and implement field efficacy trials for controlling the Senegalese grasshopper in Mali, West Africa and conduct environmental impact studies assessing non-target effects on keystone invertebrate species.

Annapolis, Maryland

The Maryland Gypsy Moth Integrated Pest Management Pilot Project was a 5-year (1983-87) cooperative effort between the State Department of Agriculture and the State and Private Forestry branch of the Forest Service. The stated goal was to evaluate the feasibility of managing the gypsy moth at low levels over a wide range of ecological, geographical, and land-use areas. The project was successful in reducing low-density gypsy moth populations and in identifying the need to develop additional technologies, such as biopesticides, for use in environmentally sensitive areas. This Pilot Project also provided a demonstration of the IPM concept over a regional scale.

Doctor Of Philosophy (Ph.D.), Biological Sciences, 3.95

Master Of Business Administration (M.B.A.), Finance, 4.0

Activities and Societies: Recipient of the Edward J Stegman Award for Excellence in Business Studies

Master'S Degree, Biology/Biological Sciences, General, 3.95

Bachelor Of Arts (B.A.), Biology

Activities and Societies: Special project course in advanced biologyRecruited to research the food partitioning of the Big Brown Bat.

Military College-Preparatory Curriculum

Activities and Societies: Varsity Cross Country, Varsity Track & Field, & Captain of the Rifle teamMcDonogh School is a private.

Education record